Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veglin with Pemetrexed and Cisplatin in Advanced Malignant Mesothelioma
NCT00668499Phase 2Withdrawn
- Sponsor
- University of Southern California
- Start
- Apr 2008
- Primary completion
- Apr 2011
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of veglin in malignant mesothelioma, sponsored by University of Southern California. Planned start Apr 2008; status: withdrawn.
02
Drugs
veglin
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00668499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668499.